Urosepsis 30-day mortality, morbidity, and their risk factors: SERPENS study, a prospective, observational multi-center study - Poll - MDSpire

Urosepsis 30-day mortality, morbidity, and their risk factors: SERPENS study, a prospective, observational multi-center study

  • By

  • Zafer Tandogdu

  • Bela Koves

  • Slobodan Ristovski

  • Mustafa Bahadir Can Balci

  • Kristin Rennesund

  • Stavros Gravas

  • DjordJe Nale

  • José Medina-Polo

  • Mária Kopilec Garabášová

  • Elisabetta Costantini

  • Jorge Cano-Valasco

  • Maja Sofronievska Glavinova

  • Franck Bruyere

  • Tamara Perepanova

  • Ekaterina Kulchavenya

  • Mete Cek

  • Florian Wagenlehner

  • Truls Erik Bjerklund Johansen

  • May 10, 2024

  • 0 min

Share

Original Source(s)

Urosepsis 30-day mortality, morbidity, and their risk factors: SERPENS study, a prospective, observational multi-center study

  • by Zafer Tandogdu, Bela Koves, Slobodan Ristovski, Mustafa Bahadir Can Balci, Kristin Rennesund, Stavros Gravas, DjordJe Nale, José Medina-Polo, Mária Kopilec Garabášová, Elisabetta Costantini, Jorge Cano-Valasco, Maja Sofronievska Glavinova, Franck Bruyere, Tamara Perepanova, Ekaterina Kulchavenya, Mete Cek, Florian Wagenlehner, Truls Erik Bjerklund Johansen

  • May 10, 2024

Related Content

Infectious complications after transrectal MRI-targeted and systematic prostate biopsy

Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003–2013

Human neutrophils recognize group B streptococci via formylated peptide receptors and toll-like receptor 8